Alibaba Health Information Technology (TWY) Stock Forecast & Price Target
TWY Analyst Ratings
Strong Buy
3Buy1Hold0Sell
Based on 4 analysts giving stock ratings to Alibaba Health Information Technology in the past 3 months
TWY Stock 12 Month Forecast
Average Price Target
CHF 0.44▲(48.63% Upside)Based on 4 Wall Street analysts offering 12 month price targets for Alibaba Health Information Technology in the last 3 months. The average price target is CHF 0.44 with a high forecast of CHF 0.47 and a low forecast of CHF 0.38. The average price target represents a 48.63% change from the last price of CHF 0.30.
Past 12 Months12 Month ForecastDec2025Sep2026
HighCHF 0.47
AverageCHF 0.44
LowCHF 0.38
Highest Price TargetHighestCHF 0.47Average Price TargetCHF 0.44Lowest Price TargetLowestCHF 0.38
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
 Hongda ZhongNot Ranked | Jefferies | CHF 0.47 | buy | 58.87%Upside | Reiterated | 09/30/26 | ||
| Lincoln Kong | Goldman Sachs | CHF 0.44→CHF 0.38 | hold | 27.10%Upside | Reiterated | 09/22/26 | ||
| Unknown AnalystNot Ranked | Huatai Securities | CHF 0.45 | buy | 49.69%Upside | Reiterated | 09/22/26 | ||
| Unknown AnalystNot Ranked | CICC | CHF 0.47 | buy | 58.87%Upside | Reiterated | 09/21/26 | ||
| Alexis Yan | Morgan Stanley | CHF 0.44 | sell | 48.28%Upside | Reiterated | 05/15/26 | ||
| Unknown AnalystNot Ranked | UOB Kay Hian | CHF 0.63 | buy | 111.83%Upside | Reiterated | 04/14/26 | ||
| Unknown AnalystNot Ranked | Bank of America Securities | CHF 0.63 | buy | 111.83%Upside | Reiterated | 04/14/26 | ||
| Unknown AnalystNot Ranked | GF Securities | CHF 0.78→CHF 0.66 | buy | 122.07%Upside | Reiterated | 04/09/26 | ||
| Unknown AnalystNot Ranked | CLSA | CHF 0.56 | buy | 87.11%Upside | Reiterated | 04/08/26 | ||
| Unknown AnalystNot Ranked | UBS | CHF 0.43 | sell | 44.75%Upside | Reiterated | 04/07/26 | ||
| Unknown AnalystNot Ranked | HSBC | CHF 0.68 | hold | 129.48%Upside | Reiterated | 02/09/26 | ||
| Unknown AnalystNot Ranked | Citi | CHF 0.95 | buy | 217.74%Upside | Reiterated | 02/05/26 | ||
| Unknown AnalystNot Ranked | Citic Securities | CHF 1.27 | buy | 327.19%Upside | Reiterated | 01/15/26 | ||
| Unknown AnalystNot Ranked | Guotai Haitong | CHF 0.60 | buy | 100.88%Upside | Reiterated | 12/03/25 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Hongda ZhongNot Ranked | 09/30/26 | CHF 0.47 | buy | 58.87%Upside | Reiterated | Jefferies | ||
| Lincoln Kong | 09/22/26 | CHF 0.44→CHF 0.38 | hold | 27.10%Upside | Reiterated | Goldman Sachs | ||
| Unknown AnalystNot Ranked | 09/22/26 | CHF 0.45 | buy | 49.69%Upside | Reiterated | Huatai Securities | ||
| Unknown AnalystNot Ranked | 09/21/26 | CHF 0.47 | buy | 58.87%Upside | Reiterated | CICC | ||
| Alexis Yan | 05/15/26 | CHF 0.44 | sell | 48.28%Upside | Reiterated | Morgan Stanley | ||
| Unknown AnalystNot Ranked | 04/14/26 | CHF 0.63 | buy | 111.83%Upside | Reiterated | UOB Kay Hian | ||
| Unknown AnalystNot Ranked | 04/14/26 | CHF 0.63 | buy | 111.83%Upside | Reiterated | Bank of America Securities | ||
| Unknown AnalystNot Ranked | 04/09/26 | CHF 0.78→CHF 0.66 | buy | 122.07%Upside | Reiterated | GF Securities | ||
| Unknown AnalystNot Ranked | 04/08/26 | CHF 0.56 | buy | 87.11%Upside | Reiterated | CLSA | ||
| Unknown AnalystNot Ranked | 04/07/26 | CHF 0.43 | sell | 44.75%Upside | Reiterated | UBS | ||
| Unknown AnalystNot Ranked | 02/09/26 | CHF 0.68 | hold | 129.48%Upside | Reiterated | HSBC | ||
| Unknown AnalystNot Ranked | 02/05/26 | CHF 0.95 | buy | 217.74%Upside | Reiterated | Citi | ||
| Unknown AnalystNot Ranked | 01/15/26 | CHF 1.27 | buy | 327.19%Upside | Reiterated | Citic Securities | ||
| Unknown AnalystNot Ranked | 12/03/25 | CHF 0.60 | buy | 100.88%Upside | Reiterated | Guotai Haitong |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Best Analysts Covering Alibaba Health Information Technology
3 Months
Success Rate3/3 ratings generated profit
100%
Average Return
+9.37%
Copying Alexis Yan's trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +9.37% per trade.
1 Year
Success Rate3/3 ratings generated profit
100%
Average Return
+36.20%
Copying Alexis Yan's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +36.20% per trade.
2 Years
Success Rate3/3 ratings generated profit
100%
Average Return
+36.20%
Copying Alexis Yan's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +36.20% per trade.
TWY Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 0 | 2 | 2 |
| Buy | 7 | 2 | 0 | 1 | 1 |
| Hold | 2 | 1 | 0 | 1 | 1 |
| Sell | 2 | 1 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 12 | 5 | 0 | 4 | 4 |
In the current month, TWY has received 3 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. TWY average Analyst price target in the past 3 months is 0.44.
TWY Financial Forecast
HighCHF 0.01
ConsensusCHF 0.01
LowCHF 0.01
TWY Earnings Forecast
Next quarter’s earnings estimate for TWY is CHF 0.01 with a range of CHF 0.01 to CHF 0.01. The previous quarter’s EPS was CHF 0.01. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
HighCHF 2.24B
ConsensusCHF 2.23B
LowCHF 2.21B
TWY Sales Forecast
Next quarter’s sales forecast for TWY is CHF 2.23B with a range of CHF 2.21B to CHF 2.24B. The previous quarter’s sales results were CHF 2.05B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
TWY Stock Forecast FAQ
What is CH:TWY’s average 12-month price target, according to analysts?
Based on analyst ratings, Alibaba Health Information Technology’s 12-month average price target is CHF0.44.
What is CH:TWY’s upside potential, based on the analysts’ average price target?
Alibaba Health Information Technology has 48.63% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Alibaba Health Information Technology a Buy, Sell or Hold?
Alibaba Health Information Technology has a consensus rating of Strong Buy, which is based on 3 buy ratings, 1 hold ratings and 0 sell ratings.
What is Alibaba Health Information Technology’s share price target?
The average share price target for Alibaba Health Information Technology is CHF0.44. This is based on 4 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is CHF0.47, and the lowest forecast is CHF0.38. The average share price target represents a 48.63% increase from the current price of CHF0.298.
What do analysts say about Alibaba Health Information Technology?
Alibaba Health Information Technology’s analyst rating consensus is a Strong Buy. This is based on the ratings of 4 Wall Street analysts.
How can I buy shares of Alibaba Health Information Technology?
To buy shares of CH:TWY, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
